Mirae Asset Global Investments Co., Ltd. Harrow Health, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,283 shares of HROW stock, worth $43,044. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,283
Previous 1,056
21.5%
Holding current value
$43,044
Previous $22,000
159.09%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HROW
# of Institutions
176Shares Held
21.4MCall Options Held
845KPut Options Held
717K-
Opaleye Management Inc. Boston, MA3.99MShares$134 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$72.6 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$72.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$62.6 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$24.5 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $908M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...